Literature DB >> 6184940

The release of histamine from the pars flaccida mast cells one cause of otitis media with effusion?

P E Alm, G D Bloom, S Hellström, B Salén, L E Stenfors.   

Abstract

In this experimental study in the rat, compound 48/80--a potent degranulating drug of mast cells--was instilled in the external auditory meatus towards the tympanic membrane. Moreover, effusion material was produced in the attic space by blocking the tympanic isthmus with a piece of Gelfoam applied through the tympanic bulla. Both these procedures caused a degranulation of the pars flaccida mast cells and subsequently histamine was detected in the rinsing fluid collected from the middle ear cavity. A possible direct cause of the effusion material in the middle ear cavity may be a degranulation of the pars flaccida mast cells, thus resembling an allergic reaction Type I.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6184940     DOI: 10.3109/00016488209128942

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  Sequential analysis of serum proteins in middle ear effusions. A study in rats with experimentally induced serous and purulent otitis media.

Authors:  U Johansson; S Hellström; L E Stenfors; T Stigbrand
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

2.  Mast cells in the pars flaccida of the tympanic membrane. a quantitative morphological and biochemical study in the rat.

Authors:  P E Alm; G D Bloom; S Hellström; L E Stenfors; L Widemar
Journal:  Experientia       Date:  1983-03-15

3.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.